Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 160

1.

Cardiomyocyte glucocorticoid and mineralocorticoid receptors directly and antagonistically regulate heart disease in mice.

Oakley RH, Cruz-Topete D, He B, Foley JF, Myers PH, Xu X, Gomez-Sanchez CE, Chambon P, Willis MS, Cidlowski JA.

Sci Signal. 2019 Apr 16;12(577). pii: eaau9685. doi: 10.1126/scisignal.aau9685.

PMID:
30992401
2.

Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle-Specific Ubiquitin Ligase MuRF1.

Willis MS, Parry TL, Brown DI, Mota RI, Huang W, Beak JY, Sola M, Zhou C, Hicks ST, Caughey MC, D'Agostino RB Jr, Jordan J, Hundley WG, Jensen BC.

Circ Heart Fail. 2019 Mar;12(3):e005234. doi: 10.1161/CIRCHEARTFAILURE.118.005234.

PMID:
30871347
3.

F-box protein-32 down-regulates small-conductance calcium-activated potassium channel 2 in diabetic mouse atria.

Ling TY, Yi F, Lu T, Wang XL, Sun X, Willis MS, Wu LQ, Shen WK, Adelman JP, Lee HC.

J Biol Chem. 2019 Mar 15;294(11):4160-4168. doi: 10.1074/jbc.RA118.003837. Epub 2019 Jan 11.

PMID:
30635400
4.

The sympathetic nervous system regulates skeletal muscle motor innervation and acetylcholine receptor stability.

Rodrigues ACZ, Messi ML, Wang ZM, Abba MC, Pereyra A, Birbrair A, Zhang T, O'Meara M, Kwan P, Lopez EIS, Willis MS, Mintz A, Files DC, Furdui C, Oppenheim RW, Delbono O.

Acta Physiol (Oxf). 2019 Mar;225(3):e13195. doi: 10.1111/apha.13195. Epub 2018 Oct 22.

PMID:
30269419
5.

Muscle-specific regulation of right ventricular transcriptional responses to chronic hypoxia-induced hypertrophy by the muscle ring finger-1 (MuRF1) ubiquitin ligase in mice.

Oakley RH, Campen MJ, Paffett ML, Chen X, Wang Z, Parry TL, Hillhouse C, Cidlowski JA, Willis MS.

BMC Med Genet. 2018 Sep 21;19(1):175. doi: 10.1186/s12881-018-0670-1.

6.

Disrupted structure and aberrant function of CHIP mediates the loss of motor and cognitive function in preclinical models of SCAR16.

Shi CH, Rubel C, Soss SE, Sanchez-Hodge R, Zhang S, Madrigal SC, Ravi S, McDonough H, Page RC, Chazin WJ, Patterson C, Mao CY, Willis MS, Luo HY, Li YS, Stevens DA, Tang MB, Du P, Wang YH, Hu ZW, Xu YM, Schisler JC.

PLoS Genet. 2018 Sep 17;14(9):e1007664. doi: 10.1371/journal.pgen.1007664. eCollection 2018 Sep.

7.

Adverse Effects of Fenofibrate in Mice Deficient in the Protein Quality Control Regulator, CHIP.

Ravi S, Parry TL, Willis MS, Lockyer P, Patterson C, Bain JR, Stevens RD, Ilkayeva OR, Newgard CB, Schisler JC.

J Cardiovasc Dev Dis. 2018 Aug 15;5(3). pii: E43. doi: 10.3390/jcdd5030043.

8.

Untargeted metabolomics analysis of ischemia-reperfusion-injured hearts ex vivo from sedentary and exercise-trained rats.

Parry TL, Starnes JW, O'Neal SK, Bain JR, Muehlbauer MJ, Honcoop A, Ilaiwy A, Christopher P, Patterson C, Willis MS.

Metabolomics. 2018 Jan;14(1):8. doi: 10.1007/s11306-017-1303-y. Epub 2017 Dec 4.

9.

Image-Based Methods for Phase Estimation, Gating, and Temporal Superresolution of Cardiac Ultrasound.

Chittajallu DR, McCormick M, Gerber S, Czernuszewicz TJ, Gessner R, Willis MS, Niethammer M, Kwitt R, Aylward SR.

IEEE Trans Biomed Eng. 2019 Jan;66(1):72-79. doi: 10.1109/TBME.2018.2823279. Epub 2018 Apr 24.

PMID:
29993406
10.

Increasing Cardiomyocyte Atrogin-1 Reduces Aging-Associated Fibrosis and Regulates Remodeling in Vivo.

Mota R, Parry TL, Yates CC, Qiang Z, Eaton SC, Mwiza JM, Tulasi D, Schisler JC, Patterson C, Zaglia T, Sandri M, Willis MS.

Am J Pathol. 2018 Jul;188(7):1676-1692. doi: 10.1016/j.ajpath.2018.04.007. Epub 2018 May 23.

PMID:
29758183
11.

Applicability of Precision Medicine Approaches to Managing Hypertension in Rural Populations.

Halladay JR, Lenhart KC, Robasky K, Jones W, Homan WF, Cummings DM, Cené CW, Hinderliter AL, Miller CL, Donahue KE, Garcia BA, Keyserling TC, Ammerman AS, Patterson C, DeWalt DA, Johnston LF, Willis MS, Schisler JC.

J Pers Med. 2018 Apr 30;8(2). pii: E16. doi: 10.3390/jpm8020016.

12.

Modeling the Transition From Decompensated to Pathological Hypertrophy.

Pascual F, Schisler JC, Grevengoed TJ, Willis MS, Coleman RA.

J Am Heart Assoc. 2018 Apr 5;7(8). pii: e008293. doi: 10.1161/JAHA.117.008293.

13.

Genome-wide association study of homocysteine in African Americans from the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Coronary Artery Risk in Young Adults study.

Raffield LM, Ellis J, Olson NC, Duan Q, Li J, Durda P, Pankratz N, Keating BJ, Wassel CL, Cushman M, Wilson JG, Gross MD, Tracy RP, Rich SS, Reiner AP, Li Y, Willis MS, Lange EM, Lange LA.

J Hum Genet. 2018 Mar;63(3):327-337. doi: 10.1038/s10038-017-0384-9. Epub 2018 Jan 10.

14.

The role of heat shock proteins and co-chaperones in heart failure.

Ranek MJ, Stachowski MJ, Kirk JA, Willis MS.

Philos Trans R Soc Lond B Biol Sci. 2018 Jan 19;373(1738). pii: 20160530. doi: 10.1098/rstb.2016.0530. Review.

15.

Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all.

Abdullah M, Berthiaume JM, Willis MS.

Transl Res. 2018 May;195:48-61. doi: 10.1016/j.trsl.2017.10.012. Epub 2017 Nov 7. Review.

16.

Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease.

Ravi S, Schuck RN, Hilliard E, Lee CR, Dai X, Lenhart K, Willis MS, Jensen BC, Stouffer GA, Patterson C, Schisler JC.

Am J Pathol. 2017 Dec;187(12):2895-2911. doi: 10.1016/j.ajpath.2017.08.006. Epub 2017 Nov 16.

17.

Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor Inhibition.

Stuhlmiller TJ, Zawistowski JS, Chen X, Sciaky N, Angus SP, Hicks ST, Parry TL, Huang W, Beak JY, Willis MS, Johnson GL, Jensen BC.

J Am Heart Assoc. 2017 Oct 19;6(10). pii: e006635. doi: 10.1161/JAHA.117.006635.

18.

Nebulized Delivery of the MAPKAP Kinase 2 Peptide Inhibitor MMI-0100 Protects Against Ischemia-Induced Systolic Dysfunction.

Brown DI, Cooley BC, Quintana MT, Lander C, Willis MS.

Int J Pept Res Ther. 2016 Sep;22(3):317-324. doi: 10.1007/s10989-015-9507-3. Epub 2016 Jan 9.

19.

Post-translationally modified muscle-specific ubiquitin ligases as circulating biomarkers in experimental cancer cachexia.

Mota R, Rodríguez JE, Bonetto A, O'Connell TM, Asher SA, Parry TL, Lockyer P, McCudden CR, Couch ME, Willis MS.

Am J Cancer Res. 2017 Sep 1;7(9):1948-1958. eCollection 2017.

20.

Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysis.

Jensen BC, Parry TL, Huang W, Beak JY, Ilaiwy A, Bain JR, Newgard CB, Muehlbauer MJ, Patterson C, Johnson GL, Willis MS.

Br J Pharmacol. 2017 Dec;174(24):4797-4811. doi: 10.1111/bph.14062. Epub 2017 Nov 24.

Supplemental Content

Loading ...
Support Center